The scope, presentation, and management of genitourinary complications in patients presenting with high-grade urethral complications after radiotherapy for prostate cancer

被引:7
作者
Doiron, R. Christopher [1 ]
Witten, Jon [1 ]
Rourke, Keith F. [1 ]
机构
[1] Univ Alberta, Dept Surg, Div Urol, Edmonton, AB, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2021年 / 15卷 / 01期
关键词
RADIATION-THERAPY; RADICAL PROSTATECTOMY; TOXICITY; SURGERY;
D O I
10.5489/cuaj.6599
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The scope of complications arising after radiotherapy (RT) treatment for prostate cancer is under-recognized and not well-described. The objective of this study is to describe the presentation, scope, and management of genitourinary (GU) complications in patients referred for high-grade urethral complications or sphincter weakness incontinence after prostate RT. Methods: A retrospective review was performed of patients referred to a reconstructive urologist for management of grade 4 urethral complications and sphincter weakness incontinence after prostate RT from December 2004 to December 2015. Patients' signs, symptoms, complications, and treatments are described. Results: A total of 120 patients were identified, with a mean age of 67.8 years; 55.8% (n=67) received external beam radiotherapy (EBRT), 38.3% (n=46) brachytherapy (BT), and 5.8% (n=7) combination RT. The mean time to first complication after RT was 57.7 months ( 1-219) and number of complications per patient was 5.1 +/- 2.2. The most common associated complications were urethral stenosis (n=106, 88.3%), sphincter weakness urinary incontinence (n=55, 45.8%), radiation cystitis (n=61, 50.8%), refractory storage lower urinary tract symptoms (n=106, 88.3%), GU pain (n=28, 23.3%), and prostate necrosis/abscess (n= 17, 14.2%). Patients required a mean of 7.4 +/- 4.4 treatments over a 33-month period, including urethral dilation/urethrotomy (n= 93, 77.5%), urethroplasty (n=53, 44.2%), transurethral resection (n=52, 43.3%), cystolithopaxy (n=14, 11.7%), artificial urinary sphincter (n=8, 6.7%), and urinary diversion (n=8, 6.7%). Patients with RT combined with other modalities had more complications (6.2 vs. 4.2, p=0.001), higher rates of incontinence (93.8% vs. 29.5%, p=0.001), necrosis (31.3% vs. 8.0%, p=0.003), erectile dysfunction (84.4% vs. 51.1%, p=0.001), and hematuria (59.4% vs. 36.4%, p=0.04). Conclusions: Urethral complications related to prostate RT are seldom an isolated problem and require a substantial amount of urological resources and interventions.
引用
收藏
页码:E6 / E10
页数:5
相关论文
共 17 条
[1]   Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis [J].
Awad, Mohannad A. ;
Gaither, Thomas W. ;
Osterberg, E. Charles ;
Murphy, Gregory P. ;
Baradaran, Nima ;
Breyer, Benjamin N. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (02) :168-174
[2]   Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature [J].
Budaeus, Lars ;
Bolla, Michel ;
Bossi, Alberto ;
Cozzarini, Cesare ;
Crook, Juanita ;
Widmark, Anders ;
Wiegel, Thomas .
EUROPEAN UROLOGY, 2012, 61 (01) :112-127
[3]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[4]   URINARY OBSTRUCTION IN PROSTATE CANCER PATIENTS FROM THE DUTCH TRIAL (68 GY VS. 78 GY): RELATIONSHIPS WITH LOCAL DOSE, ACUTE EFFECTS, AND BASELINE CHARACTERISTICS [J].
Heemsbergen, Wilma D. ;
Al-Mamgani, Abrahim ;
Witte, Marnix G. ;
van Herk, Marcel ;
Pos, Floris J. ;
Lebesque, Joos V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01) :19-25
[5]   SIU/ICUD Consultation on Urethral Strictures: Posterior Urethral Stenosis After Treatment of Prostate Cancer [J].
Herschorn, Sender ;
Elliott, Sean ;
Coburn, Michael ;
Wessells, Hunter ;
Zinman, Leonard .
UROLOGY, 2014, 83 (03) :S59-S70
[6]   PHASE II TRIAL OF COMBINED HIGH-DOSE-RATE BRACHYTHERAPY AND EXTERNAL BEAM RADIOTHERAPY FOR ADENOCARCINOMA OF THE PROSTATE: PRELIMINARY RESULTS OF RTOG 0321 [J].
Hsu, I-Chow ;
Bae, Kyounghwa ;
Shinohara, Katsuto ;
Pouliot, Jean ;
Purdy, James ;
Ibbott, Geoffrey ;
Speight, Joycelyn ;
Vigneault, Eric ;
Ivker, Robert ;
Sandler, Howard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03) :751-758
[7]   Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both [J].
Jarosek, Stephanie L. ;
Virnig, Beth A. ;
Chu, Haitao ;
Elliott, Sean P. .
EUROPEAN UROLOGY, 2015, 67 (02) :273-280
[8]  
Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.21254]
[9]   Nomograms to predict late urinary toxicity after prostate cancer radiotherapy [J].
Mathieu, Romain ;
Ospina Arango, Juan David ;
Beckendorf, Veronique ;
Delobel, Jean-Bernard ;
Messai, Taha ;
Chira, Ciprian ;
Bossi, Alberto ;
Prise, Elisabeth Le ;
Guerif, Stephane ;
Simon, Jean-Marc ;
Dubray, Bernard ;
Zhu, Jian ;
Lagrange, Jean-Leon ;
Pommier, Pascal ;
Gnep, Khemara ;
Acosta, Oscar ;
De Crevoisier, Renaud .
WORLD JOURNAL OF UROLOGY, 2014, 32 (03) :743-751
[10]   Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review [J].
Matta, Rano ;
Chapple, Christopher R. ;
Fisch, Margit ;
Heidenreich, Axel ;
Herschorn, Sender ;
Kodama, Ronald T. ;
Koontz, Bridget F. ;
Murphy, Declan G. ;
Nguyen, Paul L. ;
Nam, Robert K. .
EUROPEAN UROLOGY, 2019, 75 (03) :464-476